Dr Chen on the Investigation of CDK4/6 Inhibitors in Early-Stage Breast Cancer
Nan Chen, MD, discusses the investigation of CDK4/6 inhibitors in early-stage breast cancer.
Source: onclive.com
Stay updated with breaking news from Science Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nan Chen, MD, discusses the investigation of CDK4/6 inhibitors in early-stage breast cancer.
Catherine C. Coombs, MD, discusses strategies for disease classification and management for patients with acute myeloid leukemia.
Petros Grivas, MD, PhD, discusses frontline treatment options for patients with metastatic renal cell carcinoma.
Mikkael A. Sekeres, MD, MS, discusses the utility of myelodysplastic syndromes risk stratification systems.
Anne Favret, MD on FDA Approval of Capivasertib (Truqap) in Combination with Fulvestrant for HR-positive, HER2-negative Breast Cancer